MetaCap

ADARx Pharmaceuticals (ADRX) vs uniQure N.V. (QURE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ADARx Pharmaceuticals is the larger company by market cap ($1.42 billion vs $1.36 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADRX-33.90%QURE-49.39%
+9%-21%-52%
Sep 25, 20261 yearNov 20, 2026
ADRX-33.90%QURE-49.39%
+2%-25%-52%
Sep 21, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADRX versus QURE key metrics
MetricADRXQURE
Share price$12.79$19.35
Market cap$1.42B$1.36B
1-day change-9.68%-4.35%
YTD return—-19.14%
1-year return—-30.42%
5-year return—-32.86%
EPS (TTM)$-6.75$-3.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$16.10M
Revenue growth (YoY)—-40.64%
Net income (latest FY)—$-198.97M
Gross margin—89.53%
Operating margin—-1151.38%
Net margin—-1236.00%
52-week high$23.21$51.72
52-week low$12.50$8.73
Distance from 52-week high-44.89%-62.59%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+167.79%+207.03%
Average volume650.63K2.26M
Shares outstanding111.19M70.14M
Employees100221
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ADARx Pharmaceuticals

ADRX stock →

ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

About uniQure N.V.

QURE stock →

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees

ADRX vs QURE FAQ

Which is bigger, ADARx Pharmaceuticals or uniQure N.V.?

ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.42B compared with $1.36B for uniQure N.V. (QURE).

Are ADARx Pharmaceuticals and uniQure N.V. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons